ReSync announces round of pre-seed funding from Caffeinated Capital, Atria Ventures, and Ramsey Homsany, co-founder of Octant Bio The company’s platform is designed to be a plug-and-play tool that streamlines how companies manage data and advance assets SAN FRANCISCO — ReSync Bio, a scientific software provider accelerating preclinical R&D, today announced the company’s launch and […]

Tokyo, Japan; Rigaku Holdings Corporation, a global solution partner for X‐ray analysis (headquarters: Akishima, Tokyo; president and CEO: Jun Kawakami; “Rigaku”), has been approved for a new listing of its shares of common stock on the Tokyo Stock Exchange Prime Market today. The listing date is scheduled for October 25, 2024, and from the same […]

Highlights Include the Company’s Industry-Leading Businesses, Proven Growth Strategy, and Outstanding Long-Term Financial Outlook WALTHAM, Mass.Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, hosted its 2024 Investor Day today and provided an in-depth review of the company’s proven growth strategy and its industry-leading businesses, which consistently deliver best-in-class products and services […]

Montreal – Nomic Bio (“Nomic”), the Protein Profiling company, today announces the completion of an oversubscribed $42 million Series B funding round. The fresh capital will enable Nomic to accelerate the expansion of its commercial operations, further invest in advancing its state-of-the-art protein profiling platform, and broaden its transformative offerings to meet growing demand. The […]

IonOpticks responds to growing global market needs for proteomics tools by partnering with Nordic private equity firm MELBOURNE, Australia and STOCKHOLM — IonOpticks, a leading global producer of high-performance chromatography columns, announces its partnership with Adelis Equity Partners (“Adelis”). The Nordic private equity firm is renowned for partnering with and accelerating the growth of companies in their […]

CytoTronics, Inc., a pioneer of semiconductor-based platforms for discovery in cell biology, today announced a $13.5 million seed extension financing and the appointment of Sameer Rohatgi of LYFE Capital to their Board of Directors. The Series Seed 2 round was led by new investor, LYFE Capital, and existing investor Anzu Partners. New investors including Legend Star, RIT Venture Fund (Rochester […]

Tokyo, Japan. / Redwood City, CA — ThinkCyte today announced the successful completion of its Series C funding round. Including the equity financing secured last November, the company raised an additional $15 million in the extension round, bringing the total to $32 million. The extension round was led by Japan Green Investment Corp. for Carbon Neutrality […]

Munich, DE – Biotech startup IRUBIS, developing a state-of- the – art real – time bioprocess monitoring solution, has successfully closed a pre- series A funding round. The financing round was led by BioProcess360 Partners, with participation from previous investors such as High-Tech Gründerfonds (HTGF), Verve Ventures, Ventura BioMed Investors, RoBet KG as well as […]

Thomas Unt, the CEO of SmiLe Inject Capital Lund, Sweden – SmiLe Inject Capital, an investment company under the SmiLe Venture Hub umbrella, is investing a total of 9 million SEK (0,8 million euros) in three promising life science startups: Uman Sense, Nygen Analytics, and Aligned Bio. All three companies are members of SmiLe and […]

Phase Holographic Imaging (PHI) is thrilled to announce its official approval for listing on the OTCQB Venture Market in the U.S., with trading commencing yesterday, Thursday, August 15th. This marks an important milestone in expanding our reach and enhancing accessibility for U.S. investors, setting the stage for improved engagement and continued growth. Effective August 15th, […]